Anne Holbrook, McMaster University
Medicine
Professor
Hamilton, Ontario
holbrook@mcmaster.ca
Office:
(905) 522-1155 ext. 5269
Expert In
Bio/Research
Dr Holbrook is the Director of the Division of Clinical Pharmacology, Department of Medicine, McMaster University; Professor, Department of Medicine, McMaster University and Senior Scientist, Centre for Evaluation of Medicines, St. Joseph's Healthcare Hamilton. She trained in clinical pharmacy, c...
Click to Expand >>
Click to Expand >>
Bio/Research
Dr Holbrook is the Director of the Division of Clinical Pharmacology, Department of Medicine, McMaster University; Professor, Department of Medicine, McMaster University and Senior Scientist, Centre for Evaluation of Medicines, St. Joseph's Healthcare Hamilton. She trained in clinical pharmacy, clinical pharmacology, medicine, internal medicine and clinical epidemiology at the University of Toronto, Philadelphia College, McGill University and McMaster University.
She is an Active Medical Staff member of Hamilton Health Sciences and St Joseph 's Healthcare Hamilton, leading an internal medicine and clinical pharmacology teaching service specializing in the management of complex, hospitalized adults with multiple diagnoses, multiple medications, drug-related harms or intolerances, or medication access issues.
She is one of the most senior drug policy expert advisors in the country, having advised governments and public payers at the federal, provincial and regional levels for several decades on comparative effectiveness, safety and cost-effectiveness of medications. Decisions taken currently influence more than $10 billion worth of medication expenditures annually.
Click to Shrink <<
She is an Active Medical Staff member of Hamilton Health Sciences and St Joseph 's Healthcare Hamilton, leading an internal medicine and clinical pharmacology teaching service specializing in the management of complex, hospitalized adults with multiple diagnoses, multiple medications, drug-related harms or intolerances, or medication access issues.
She is one of the most senior drug policy expert advisors in the country, having advised governments and public payers at the federal, provincial and regional levels for several decades on comparative effectiveness, safety and cost-effectiveness of medications. Decisions taken currently influence more than $10 billion worth of medication expenditures annually.
Click to Shrink <<